Form 4: Eli Lilly Executive Sells Shares Under 10b5-1 Trading Plan

An Eli Lilly executive, Johna Norton, sold 7,056 shares of common stock at a weighted average price of $819.38, under a pre-arranged 10b5-1 trading plan.

Summary

• Johna Norton, an Executive Vice President at Eli Lilly, sold 7,056 shares of Eli Lilly common stock.
• The sale occurred on June 3, 2024, at a weighted average price of $819.38 per share.
• The shares were sold under a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.
• The sale was executed in multiple transactions with prices ranging from $818.80 to $819.59 per share.
• Ms. Norton also has indirect ownership of 25,428 shares through a 401(k), 1,770 shares through a partner's 401(k), and 128 shares through a partner.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an executive's stock sale under a pre-arranged plan. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates a pre-planned sale, which is a common practice to avoid accusations of trading on inside information.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice among executives at publicly traded companies like Eli Lilly, similar to practices at companies such as Pfizer (PFE) and Johnson & Johnson (JNJ).
• The reported sale is consistent with typical insider trading activity, where executives periodically sell shares for personal financial management.
• The price range of the sale is within a narrow band, indicating a stable market price at the time of the transaction, which is similar to what would be expected for a large cap stock like LLY.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's overall performance or stock price.

Key Dates

Keywords

Eli Lilly, LLY, insider trading, stock sale, Form 4, 10b5-1 plan, executive, Johna Norton